NCT07381296 Prognostic Factors and Predictors of Disease Flare in Patients With Rheumatoid Arthritis
| NCT ID | NCT07381296 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Rheumatoid Arthritis Disease Flare |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2026-02-01 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to help find better ways to predict when a flare of your disease (rheumatoid arthritis) might happen. By looking at your registered data, symptoms, disease characteristics, and specific markers in your blood, the investigators hope to help doctors make better decisions about your treatment in the future. The main question it aims to answer is: Can specific patient data, disease characteristics, drug history, or markers in a patient's blood be used to predict when a rheumatoid arthritis flare is about to happen? Participants already diagnosed with rheumatoid arthritis and who have their disease controlled will be followed up every 3 months for any signs or symptoms of a flare.
Eligibility Criteria
Inclusion Criteria: * Age: patients \>18 years old. * Patients with rheumatoid arthritis diagnosed according to the 2010 American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology Classification Criteria for RA. * Clinical remission or low disease activity according to the disease activity score in 28 joints (DAS28). Exclusion Criteria: * Age \< 18 years. * Any autoimmune disease other than Rheumatoid arthritis. Severe infection, pregnancy, and malignancy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07381296 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Rheumatoid Arthritis Disease Flare. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07381296 currently recruiting?
Yes, NCT07381296 is actively recruiting participants. Contact the research team at esraamahmoud@med.sohag.edu.eg for enrollment information.
Where is the NCT07381296 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT07381296 clinical trial?
NCT07381296 is sponsored by Sohag University. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.